Study of Efficacy and Safety of CVAA489 in Hypertensive Patients

Clinical trial NCT02062645 · COMPLETED

Trial details

NCT number: NCT02062645
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2014-02-01
Primary completion: 2015-09-01
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.